Endometrial Cancer (EC) is the commonest gynecological cancer and its incidence is
increasing. The diagnosis of endometrial carcinoma in young women of childbearing age is …

Endometrial cancer (EC) is the fifth most common cancer in women worldwide. Global
estimates show rising incidence rates in both developed and developing countries. Most …

STUDY QUESTION How should fertility-sparing treatment of patients with endometrial
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …

OBJECTIVE: To assess efficacy of the levonorgestrel-releasing intrauterine device (LNG-
IUD) for treatment of complex atypical hyperplasia or low-grade endometrial cancer …

Background The incidence of complex atypical hyperplasia and early-stage endometrioid
endometrial cancer is increasing, in part owing to the epidemic of obesity, which is a risk …

Endometrial cancer is the most common gynecologic cancer in the United States. It is
typically diagnosed in postmenopausal women. However, given the increasing incidence of …

Objective The present study investigated long-term outcomes of medroxyprogesterone
acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia …

Objective To investigate the oncologic and reproductive outcomes after progestin treatment
of complex endometrial hyperplasia (CEH) and grade 1 endometrial carcinoma (EC) …

BACKGROUND Endometrial cancer is common and usually occurs after menopause, but
the number of women diagnosed during reproductive age is increasing. The standard …

Background Endometrial cancer and atypical hyperplasia are rare in young women but
create a dilemma between desire for pregnancy and oncologic outcomes. Objective To …